|
CollaGenex Pharmaceuticals |
|
|
41 University Drive, Ste. 200 Newtown, PA 18940 USA phone:(215) 579-7388 fax:(215) 579-8577
|
|
| Symbol |
CGPI |
| Exchange |
NASDAQ GM |
| Founded |
0 |
| Employees |
148 |
|
|
| www.collagenex.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Medical therapies to the dental and dermatology markets. |
 |
| Management |
| Colin W. Stewart, President and Chief Executive Officer; Nancy C. Broadbent, Chief Financial Officer and Treasurer; David F. Pfeiffer, Senior Vice President, Sales and Marketing; Klaus P.J. Theobald, PhD, MD, Sr. Vice President and Chief Medical Officer; J. Gregory Ford Vice President, Business Development and Strategic Planning; Andrew K.W. Powell, J.D., Vice President, General Counsel Secretary; James E. Daverman Chairman of the Board, Managing General Partner, Redfish Partners LP; Peter R. Barnett, DMD, President, Star Ranch Dental Spa; Robert A. Beardsley, PhD, President and Chief Executive Officer, Kereos, Inc.; Robert C. Black, Former President, U.S. Pharmaceuticals Division of Astra Zeneca, Inc.; Robert J. Easton, Chairman, Easton Associates, LLC; George Lasezkay, Pharm.D., J.D., President, Turning Point Consultants; W. James O'Shea, President and Chief Operating Officer, Sepracor, Inc.; Colin W. Stewart, President and Chief Executive Officer, CollaGenex Pharmaceuticals, Inc. |
| |
|
|
|
|
|
|
|
| Keywords |
| dental, dermatology |
|
|
|
| Description |
|
CollaGenex Pharmaceuticals Inc. is a specialty pharmaceutical company focused on providing medical therapies to the dental and dermatology markets. |
 |
| Products / Services |
The Company's first product, Periostat, is an orally administered prescription pharmaceutical product that was approved by the United States Food and Drug Administration in September 1998. CollaGenex also markets other pharmaceutical products under marketing and licensing agreements, including Atridox, Atrisorb FreeFlow and Atrisorb-D, Vioxx, Pandel, Avar, Denavir and Dentaplex.
|
 |
 |
|
|
|
|
|
|